- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 19/38 - Nucleosides
Patent holdings for IPC class C12P 19/38
Total number of patents in this class: 89
10-year publication summary
|
4
|
2
|
4
|
5
|
10
|
1
|
7
|
9
|
6
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Codexis, Inc. | 799 |
7 |
| Ajinomoto Co., Inc. | 2305 |
6 |
| Cellscript, LLC. | 19 |
3 |
| Enginzyme AB | 14 |
3 |
| Cure Biopharma Inc. | 5 |
3 |
| UAB "Biomatter Designs" | 9 |
3 |
| Glaxo Group Limited | 4119 |
2 |
| DSM IP Assets B.V. | 5605 |
2 |
| Asymchem Life Science (Tianjin) Co., Ltd | 88 |
2 |
| Dyadic International (USA), Inc. | 20 |
2 |
| Nature's Toolbox, Inc. | 30 |
2 |
| Merck Sharp & Dohme LLC | 3749 |
2 |
| Bristol-myers Squibb Company | 4878 |
1 |
| Bayer Cropscience LP | 365 |
1 |
| Massachusetts Institute of Technology | 10036 |
1 |
| Wisconsin Alumni Research Foundation | 3870 |
1 |
| The General Hospital Corporation | 4720 |
1 |
| The Trustees of Columbia University in the City of New York | 3566 |
1 |
| Achillion Pharmaceuticals, Inc. | 165 |
1 |
| Alnylam Pharmaceuticals, Inc. | 1152 |
1 |
| Other owners | 44 |